Compare NVGS & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVGS | OMCL |
|---|---|---|
| Founded | 1997 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Computer Manufacturing |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2013 | 2000 |
| Metric | NVGS | OMCL |
|---|---|---|
| Price | $20.65 | $37.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $21.50 | ★ $53.67 |
| AVG Volume (30 Days) | ★ 406.3K | 351.8K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.36% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | N/A | $5.22 |
| P/E Ratio | ★ $13.06 | $956.75 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $12.04 | $22.66 |
| 52 Week High | $21.36 | $51.84 |
| Indicator | NVGS | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 60.51 | 57.29 |
| Support Level | $17.38 | $32.20 |
| Resistance Level | $21.36 | $42.60 |
| Average True Range (ATR) | 0.59 | 1.38 |
| MACD | 0.09 | 0.67 |
| Stochastic Oscillator | 91.42 | 79.92 |
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). The company plays a vital role in the globalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users, and commodity traders.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.